Head Neck Cancer Clinical Trial
Official title:
Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors
Verified date | April 2016 |
Source | Vanderbilt-Ingram Cancer Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
Treatment for head and neck cancer can result in marked musculo-skeletal impairment (MSI). This study will examine the effects of Hatha Yoga as a therapeutic modality to address MSI.
Status | Completed |
Enrollment | 40 |
Est. completion date | October 2015 |
Est. primary completion date | October 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - >/= 18 years of age - >3 months post-treatment of HNC - no active cancer - ability to understand English in order to complete questionnaires - willing to participate in the guided and home Yoga practice - willing to drive to the study site - willing and able to provide informed consent - completed medically indicated physical therapy - medical clearance by study medical oncologist Exclusion Criteria: - a prior cancer diagnosis within the past three years (except basal cell, surgically treated squamous cell skin cancer, early prostate cancer under observation) - have received radiation therapy or chemotherapy for any condition other than primary HNC - medical conditions that would prohibit the safe implementation of a Yoga practice (e.g., vertigo, dementia) - active Yoga practice within the past 6 months |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
United States | Vanderbilt University School of Nursing | Nashville | Tennessee |
United States | Vanderbilt-Ingram Cancer Center | Nashville | Tennessee |
Lead Sponsor | Collaborator |
---|---|
Vanderbilt-Ingram Cancer Center | National Cancer Institute (NCI), National Institutes of Health (NIH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of patients who complete a modified Yoga program for HNC survivors | Number of patients that complete an 8-week course of guided yoga sessions and that complete a Participant Practice Log to document their non-guided home yoga sessions | at 8 weeks | No |
Secondary | Change in range of motion (ROM) jaw maximal inter-incisoral opening | Change in ROM from baseline in the jaw maximal inter-incisoral opening, measured in millimeters (mm) | at 8 weeks | No |
Secondary | Change in cervical ROM | Change from baseline in cervical ROM, measured in degrees of neck movement | at 8 weeks | No |
Secondary | Change in head and neck-related treatment systems | Change from baseline in the Vanderbilt Head and Neck Symptom Survey: 9 questions on treatment-related symptoms with 0 = least amount of problems to 10 = most amount of problems. Higher scores indicate increased treatment-related distress | at 8 weeks | No |
Secondary | Change in Brief Pain Inventory | Change from baseline in scores for the Brief Pain Inventory: 9 items with 0 = no pain to 10 = pain as bad as you can imagine. Higher sum of scores indicate greater pain burden | at 8 weeks | Yes |
Secondary | Change in Body Image Quality of Life Inventory | Change from baseline in scores in the Change in Body Image Quality of Life Inventory. 18 questions with minus 3 = very negative effect to plus 3 = very positive effect. sum of scores with higher scores indicating a more positive body image | at 8 weeks | No |
Secondary | Change in Anxiety and Depression Scale | Change from baseline in scores on the Hospital Anxiety and Depression Inventory with a score of >/= 8 as possible cause for mental health referral | 8 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04566367 -
Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer
|
N/A | |
Terminated |
NCT02521870 -
A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
|
Phase 1/Phase 2 | |
Recruiting |
NCT05572684 -
A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT02268344 -
Brief Intraoperative Electrical Stimulation for Prevention of Shoulder Dysfunction After Oncologic Neck Dissection
|
N/A | |
Terminated |
NCT00198328 -
Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma
|
Phase 3 | |
Recruiting |
NCT04858269 -
First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients
|
Phase 2 | |
Recruiting |
NCT05878964 -
Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.
|
||
Recruiting |
NCT03051269 -
Calcium Electroporation for Head and Neck Cancer
|
Phase 1 | |
Completed |
NCT05833841 -
Swallowing Function in Patients With Head and Neck Cancers
|
N/A | |
Withdrawn |
NCT03747562 -
Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients.
|
Phase 3 | |
Completed |
NCT03572829 -
Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC
|
Phase 2 | |
Completed |
NCT02075385 -
Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer
|
Phase 2 | |
Recruiting |
NCT02549742 -
Electrochemotherapy on Head and Neck Cancer
|
Phase 2 | |
Recruiting |
NCT05838729 -
Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03832686 -
Investigation of Two Swallowing Therapy Models During Radiation Therapy for Head and Neck Cancer
|
N/A | |
Recruiting |
NCT05382585 -
Newer Therapeutic Targets in Head and Neck Cancers
|